Perspectives on the Immune System in Sepsis.
Authors:
- Vol. 17 (2) , 395-403
Abstract
Beyond the modifications shown by the biochemistry labs, profound and ample modifications are seen in septic patients at a molecular level stemming from DNA translation and gene expression, manifested as unique profiles of mRNA (messenger), as well as non-coding, functional RNAs: miRNA (micro) and lncRNAs (long non-coding). Counteracting these modifications requires treatment with pleiotropic molecules and/or combination of molecules and opens the possibility of future treatments with arrays of siRNAs and/or specific panels of small molecules tailored for each patient subpopulation.Keywords
All Related Versions
This publication has 73 references indexed in Scilit:
- A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeuticseLife, 2013
- Transcriptional Instability during Evolving Sepsis May Limit Biomarker Based Risk StratificationPLOS ONE, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective StudyPLOS ONE, 2012
- Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patientsBritish Journal of Nutrition, 2011
- The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis*Critical Care Medicine, 2011
- The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8 + T cellsProceedings of the National Academy of Sciences, 2008
- Glutathione metabolism in sepsisCritical Care Medicine, 2007
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- NF-κB: A pleiotropic mediator of inducible and tissue-specific gene controlCell, 1989